Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Perrigo Company plc (PRGO : NYSE)

• Company Description    Perrigo Co. Plc engages in providing over-the-counter (OTC) self-care and wellness solutions. Its solutions enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. The firm operates through three segments: Consumer Self-Care Americas, Consumer Self-Care International and Prescription Pharmaceuticals. The Consumer Self-Care Americas segment comprises the store brand consumer self-care business in the U.S., Mexico and Canada. The Consumer Self-Care International segment includes the branded consumer self-care business in Europe, along with consumer-focused businesses in the U.K. and Australia. The Prescription Pharmaceuticals commercializes and manufactures generic prescription products in the U.S. and diagnostic products in Israel. The company was founded by Luther Perrigo in 1887 and is headquartered in Dublin, Ireland. Number of Employees: 9,900

• Price / Volume Information    Yesterday's Closing Price: $38.14 Daily Weekly Monthly 20 Day Moving Average: 1,892,934 shares Shares Outstanding: 134.54 (millions) Market Capitalization: $5,131.43 (millions) Beta: 1.02 52 Week High: $50.90 52 Week Low: $31.32 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 9.03% 22.79% 12 Week 9.13% 19.96% Year To Date -1.95% 18.04%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL THE SHARP BUILDING HOGAN PLACE - DUBLIN,L2 49010 IRL ph: 353-1709-4000 fax: 269-673-9128 investor.request@perrigo.com http://www.perrigo.com

• General Corporate Information    Officers Murray S. Kessler - Chief Executive Officer; President and Director Rolf A. Classon - Chairman Raymond P. Silcock - Chief Financial Officer Bradley A. Alford - Director Orlando D. Ashford - Director Peer Information Perrigo Company plc (BJCT) Perrigo Company plc (CADMQ) Perrigo Company plc (APNO) Perrigo Company plc (UPDC) Perrigo Company plc (IMTIQ) Perrigo Company plc (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: G97822103 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/10/22 Share - Related Items Shares Outstanding: 134.54 Most Recent Split Date: 8.00 (2.00:1) Beta: 1.02 Market Capitalization: $5,131.43 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 2.73% Current Fiscal Quarter EPS Consensus Estimate: $0.40 Indicated Annual Dividend: $1.04 Current Fiscal Year EPS Consensus Estimate: $2.31 Payout Ratio: 0.55 Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: 0.32 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 02/25/2022 - $0.26 Next EPS Report Date: 08/10/22

• Fundamental Ratios P/E Current FY Estimate: 16.55 Trailing 12 Months: 20.29 PEG Ratio: - Price Ratios Price/Book: 1.01 Price/Cash Flow: 8.71 Price / Sales: 1.22 EPS Growth vs. Year Ago Period: -34.00% vs. Previous Quarter: -45.00% Sales Growth vs. Year Ago Period: 6.39% vs. Previous Quarter: -2.75% ROE 03/31/22 - 4.88 12/31/21 - 5.19 09/30/21 - 5.88 ROA 03/31/22 - 2.38 12/31/21 - 2.53 09/30/21 - 2.87 Current Ratio 03/31/22 - 4.01 12/31/21 - 2.43 09/30/21 - 2.11 Quick Ratio 03/31/22 - 2.97 12/31/21 - 1.79 09/30/21 - 1.56 Operating Margin 03/31/22 - 6.09 12/31/21 - 6.71 09/30/21 - 7.45 Net Margin 03/31/22 - -2.07 12/31/21 - -1.12 09/30/21 - -5.86 Pre-Tax Margin 03/31/22 - 5.44 12/31/21 - 6.25 09/30/21 - 3.09 Book Value 03/31/22 - 37.94 12/31/21 - 38.51 09/30/21 - 38.76 Inventory Turnover 03/31/22 - 2.65 12/31/21 - 2.49 09/30/21 - 2.41 Debt-to-Equity 03/31/22 - 0.69 12/31/21 - 0.57 09/30/21 - 0.56 Debt-to-Capital 03/31/22 - 40.75 12/31/21 - 36.15 09/30/21 - 36.05

Powered by Zacks Investment Research ©